In a 20-year-old woman with an etonogestrel (Nexplanon) implant placed 4 months ago who wants removal due to prolonged menstrual bleeding lasting up to two weeks, what medication can be used to manage the prolonged bleeding?

Medical Management of Prolonged Bleeding with Nexplanon

For a 20-year-old woman with prolonged bleeding from Nexplanon at 4 months, first-line treatment is NSAIDs (such as mefenamic acid 500 mg three times daily or ibuprofen) for 5-7 days during bleeding episodes; if NSAIDs fail or are contraindicated, use low-dose combined oral contraceptives (COCs) or estrogen for 10-20 days as second-line therapy. 1

Initial Assessment

Before initiating treatment, rule out:

• Pregnancy (perform pregnancy test)
• Sexually transmitted infections
• New pathologic uterine conditions (polyps, fibroids)
• Medication interactions that could affect implant efficacy
• Implant displacement (confirm you can palpate the implant)

If any underlying gynecological problem is identified, treat that condition first or refer for appropriate care. 1

Treatment Algorithm

First-Line: NSAIDs (5-7 days during bleeding)

NSAIDs are the recommended initial treatment for prolonged bleeding in implant users. 1

Evidence supports:

• Mefenamic acid 500 mg three times daily for 5 days showed significant bleeding cessation within 7 days in small studies 1
• Celecoxib 200 mg daily for 5 days also demonstrated significant bleeding cessation 1
• Standard ibuprofen dosing is an alternative option

The mechanism works through prostaglandin inhibition, which reduces endometrial bleeding. Studies specifically in etonogestrel implant users found that 87.5% achieved temporary bleeding interruption with NSAID treatment, though this was in combination studies. 1

Second-Line: Hormonal Treatment (10-20 days)

If NSAIDs fail or the patient cannot tolerate them, use hormonal therapy:

• Low-dose COCs (20 mcg ethinyl estradiol/150 mcg desogestrel) for 10-20 days 1
• Estrogen alone for 10-20 days (if COCs contraindicated) 1

Recent evidence shows COCs are highly effective:

• A 2020 study found 76.2% of women stopped bleeding within 7 days using COCs containing 20 mcg ethinyl estradiol, significantly better than NSAIDs alone (35.7%) 2
• A 2015 randomized trial showed 87.5% achieved temporary bleeding interruption with a 14-day course of COCs 3
• A 2025 study demonstrated norethisterone acetate 10 mg daily stopped bleeding in 86.7% of users within 7 days 4

Important caveat: Bleeding typically recurs within 5-10 days after stopping hormonal treatment. 4, 3 These treatments provide temporary relief but do not prevent future bleeding episodes.

Treatments That Do NOT Work

• Tranexamic acid: A 2026 randomized trial specifically in Nexplanon users found no benefit over placebo for frequent or prolonged bleeding 5
• Doxycycline alone: Did not improve bleeding cessation in etonogestrel implant users 1, 6
• Aspirin: Should be avoided as it may worsen bleeding 1

Counseling and Expectations

Critical counseling points:

1. Bleeding irregularities at 4 months are common and generally not harmful - they often improve with continued use 1

2. Medical treatments provide temporary relief only - they stop the current bleeding episode but do not prevent recurrence 4, 3

3. Enhanced counseling about expected bleeding patterns reduces discontinuation rates in clinical trials 1

4. If bleeding persists despite treatment and remains unacceptable to the patient, counsel on alternative contraceptive methods and offer removal with transition to another method 1

Practical Management Approach

Step 1: Confirm implant is palpable and rule out pregnancy/STIs

Step 2: Start mefenamic acid 500 mg TID for 5 days during bleeding episodes

Step 3: If inadequate response after 1-2 cycles, switch to low-dose COCs (20 mcg ethinyl estradiol) for 10-20 days

Step 4: If bleeding remains unacceptable despite treatment, discuss implant removal and alternative contraception

Common Pitfalls to Avoid

• Do not use tranexamic acid - recent high-quality evidence shows it doesn't work for implant-related bleeding 5
• Do not attempt removal without first trying medical management - many women respond to treatment and can continue using this highly effective method
• Do not promise permanent resolution - be honest that treatments are temporary and bleeding may recur
• Do not forget to verify the implant is palpable - if you cannot feel it, localization is needed before any intervention 7

The evidence base for managing Nexplanon bleeding is limited, with most studies being small and short-term. However, the CDC guidelines 1 provide the most authoritative framework, recommending NSAIDs first-line and hormonal therapy second-line, which is supported by the available research evidence.